人类白细胞抗原G在肾移植受者外周血的表达探讨  被引量:4

Expression of human leucocyte antigen G in peripheral blood of kidney transplantation recipients

在线阅读下载全文

作  者:肖漓[1] 石炳毅[1] 蔡明[1] 何秀云[1] 许晓光[1] 韩永[1] 周文强[1] 孟晓云[1] 高钰[1] 

机构地区:[1]解放军第三零九医院器官移植中心研究室,北京100091

出  处:《中华医学杂志》2010年第4期241-244,共4页National Medical Journal of China

基  金:全军“十一五”计划科研基金科技攻关项目(06G115)

摘  要:目的探讨人类白细胞抗原(HLA)G的膜型HLA—G(mHLA—G)、胞内HIJA—G(iHLA—G)和可溶型HLA—G(sHLA—G)在。肾移植受者外周血的表达及其与术后临床相关性。方法研究对象为2000年2月至2006年6月解放军第三零九医院全军器官移植中心行肾移植的175例受者,根据4周内是否发生排斥反应分为急性排斥反应组(36例)、功能稳定组(139例),30例健康供者作为对照组。应用流式细胞术检测外周血mHLA-G1、iHLA—G1的表达,酶联免疫吸附法检测血浆sHLA-G5的含量.结果T淋巴细胞CD4^+mHlA—G1’、CD8^+mHLA—G1^+、CD4^+iHLA—G1^+、CD8^+iHLA—G1^+平均表达率在对照组分别为0.43%±0.19%、1.23%4-0.41%、27%±13%、36%±14%,急性排斥反应组分别为:0.57%±0.34%、1.31%±0.56%、26%±8%、37%±17%,功能稳定组分别为0.61%±0.43%、1.39%4-0.47%、26%±9%、37%±17%,3组间比较差异均无统计学意义(均P〉0.05)。外周血浆sHLA—G5表达在对照组为(25±14)ng/ml;急性排斥组术前为(24±15)ng/ml,术后为(34±21)ng/ml;功能稳定组术前为(25±11)ng/ml,术后为(56±32)rig/ml;急性排斥组和功能稳定组术前与健康组比较,差异无统计学意义(P〉0.05),术后功能稳定组明显高于急性排斥组(P〈0.05)。结论肾移植受者外周血存在一群比率较低的HLA—G^+T淋巴细胞,mHLA—G1和iHLA—GI的表达与肾移植术后的排斥反应发生无关,sHLA—G5的高表达与排斥反应发生的减少有关。Objective To investigate the expression of non-classical major histocompatibility complex( MHC)-I molecule, human leucocvte antigen (HLA) G, including membrane-bound HLA-G (mHI,A-G), intracellular HI,A-G (iHLA-G) and soluble HLA-G (sHLA-G), in peripheral blood of surviving kidney transplantation recipients and understand the relevance between HLA-G and the function of transplanted organ, as well as the onset of acute rejection. Methods A longitudinal study was performed on 175 kidney transplantation recipients. Three groups were involved in this study, including acute rejection group (n = 36), function stable group (n = 139) and healthy control group (n = 30). The expression of mHLA-GI and iHLA-G1 in the T lymphocytes of peripheral blood was detected by flow cytometry analysis and the sHLA-G5 level detected by ELISA. Results The average rate of CD4^+ mHLA-G1^+ , CD8^+ mHLA- G1^+ , CD4^+ iHLA-G1^+ , CD8^+ iHLA-G1^+ in T lymphocytes of healthy control group was 0. 43% ±0. 19%, 1.23% ±0.41% , 27% ± 13% and 36% ± 14% respectively. That of acute rejection group was 0.57% ± 0.34%, 1.31% ±0.56%, 26% ±8% and 37% ± 17%; that of function stable group was 0.61% ± 0. 43% , 1.39% ±0. 47% , 26% ± 9% and 37% ± 17% respectively. There was no signifieant difference among the three groups ( all P 〉 0. 05 ). The average of sHLA-G5 levels in plasma of eontrol group was (25 ± 14) ng/ml, acute rejection group (24 ±15) ng/ml (pre-operative) and (34± 21 ) ng/ml (post-operative) , function stable group ( 25 ± 11 ) ng/ml (pre-operative) and ( 56 ± 32 ) ng/ml (post-operative). There was no signifieant difference among the three groups (pre-operative, P 〉 0. 05 ). The average of sHLA-G5 levels in plasma of function stable group was higher than that of acute rejection group (post-operative, P 〈 0.05 ) . Conclusion There is a subset of CD4^+ HLA-G1^+ and CD8^+ HLA-G1^+ T lymphocytes with low percentage in periphe

关 键 词:肾移植 HLA抗原 组织相容性抗原 移植物排斥 

分 类 号:R699.2[医药卫生—泌尿科学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象